Organogenesis Holdings Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +1,033.9% | -59.9% | +24.4% | -54.0% | -172.6% | |
| – | +2,231.9% | -4.8% | -23.1% | +24.0% | +35.2% | -13.2% | +103.8% | -35.7% | +118.6% | -27.4% | +58.2% | |
| – | – | +3.1% | +94.3% | +17.0% | -12.9% | +77.5% | +132.6% | +69.6% | +37.3% | +17.6% | +25.7% | |
| – | +3,713.3% | +69.9% | -96.2% | +2,132.4% | -31.2% | +5.4% | -437.3% | – | – | – | – | |
| – | – | – | – | -1,586.2% | – | – | – | – | – | – | – | |
| – | -47.8% | +166.9% | +78.3% | -23.5% | +235.7% | +183.6% | +76.6% | +8.6% | -28.1% | -58.8% | +41.1% | |
| – | -53.7% | +79,591.5% | -95.2% | -87.5% | +235.9% | +276.9% | +32.9% | +8.6% | -28.1% | -58.8% | +41.1% | |
| – | – | – | – | – | – | – | – | -55.6% | – | – | +532.4% | |
| – | – | +1,247,900.0% | – | – | -5,782.4% | – | -101.2% | -12.1% | -48.8% | +7,574.4% | -100.0% | |
| – | +1,551.2% | +33.8% | +75.4% | -94.9% | +3,458.7% | -141.7% | – | -225.8% | +83.9% | +1,207.6% | -98.3% | |
| – | +608.9% | +2,787.8% | -100.1% | – | -3.6% | -46.1% | -102.4% | +112.3% | +150.3% | – | -162.8% | |
| – | – | +348.0% | -200.0% | – | +104.6% | -37.3% | +21.6% | -137.8% | – | +2,935.6% | -231.5% | |
| – | – | – | – | – | – | – | – | -129.4% | – | -36.3% | -685.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.